Arcturus Therapeutics Holdings, Inc. (ARCT)
13.93
+1.06
(+8.24%)
USD |
NASDAQ |
Oct 09, 10:34
Arcturus Therapeutics Holdings Price to Book Value : 2.304 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.129 |
| October 07, 2026 | 2.112 |
| October 06, 2026 | 2.151 |
| October 05, 2026 | 2.425 |
| October 02, 2026 | 2.156 |
| October 01, 2026 | 2.185 |
| September 30, 2026 | 2.265 |
| September 29, 2026 | 2.266 |
| September 28, 2026 | 2.392 |
| September 25, 2026 | 2.291 |
| September 24, 2026 | 2.336 |
| September 23, 2026 | 2.200 |
| September 22, 2026 | 2.379 |
| September 21, 2026 | 2.430 |
| September 18, 2026 | 2.652 |
| September 17, 2026 | 2.801 |
| September 16, 2026 | 2.581 |
| September 15, 2026 | 2.620 |
| September 14, 2026 | 2.530 |
| September 11, 2026 | 2.437 |
| September 10, 2026 | 2.313 |
| September 09, 2026 | 2.438 |
| September 08, 2026 | 2.586 |
| September 04, 2026 | 2.617 |
| September 03, 2026 | 2.574 |
| Date | Value |
|---|---|
| September 02, 2026 | 2.769 |
| September 01, 2026 | 2.684 |
| August 31, 2026 | 2.442 |
| August 28, 2026 | 2.513 |
| August 27, 2026 | 2.675 |
| August 26, 2026 | 2.619 |
| August 25, 2026 | 2.554 |
| August 24, 2026 | 2.372 |
| August 21, 2026 | 2.225 |
| August 20, 2026 | 1.818 |
| August 19, 2026 | 1.701 |
| August 18, 2026 | 1.358 |
| August 17, 2026 | 1.347 |
| August 14, 2026 | 1.362 |
| August 13, 2026 | 1.300 |
| August 12, 2026 | 1.257 |
| August 11, 2026 | 1.244 |
| August 10, 2026 | 1.166 |
| August 07, 2026 | 1.226 |
| August 06, 2026 | 1.006 |
| August 05, 2026 | 1.036 |
| August 04, 2026 | 1.029 |
| August 03, 2026 | 0.9926 |
| July 31, 2026 | 0.9529 |
| July 30, 2026 | 0.9794 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.624 |
| Exelixis, Inc. | 8.164 |
| Ionis Pharmaceuticals, Inc. | 17.04 |
| United Therapeutics Corp. | 3.597 |
| PTC Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 20.86 |
| PEG Ratio | -0.0857 |
| Price | 13.93 |
| Earnings Yield | -23.79% |
| Market Cap | 395.93M |
| PEGY Ratio | -0.0857 |